In addition, by integrating independent databases of TCGA and CPTAC, we further validated that the expression of SPTBN1 was significantly downregulated in tumor tissues compared with normal tissues in KIRC patients at both mRNA and protein expression levels. This evidence concerns the gene SPTBN1 and neoplasm.